Optics tissue-therapy company NuVision Biotherapies has named Tim Precious as its new Chief Executive Officer, effective 26th May 2026. The appointment marks a significant milestone
Optics tissue-therapy company NuVision Biotherapies has named Joanna Underhill as its new non-executive director. Joanna will provide an integral voice at board level, working closely
In this touching and illuminating video, we follow David as he embarks on his healing journey with the groundbreaking ocular treatment from NuVision Biotherapies. Through
Your eyes are constantly working—whether you’re staring at a screen, enjoying the sunshine, or just going about your day. But how often do you take
Attendees at this week’s prestigious Saudi Ophthalmology annual meeting – So2023 (link) from 19-21st October in Riyadh will learn about the latest clinical research outcomes
NuVision Biotherapies is honoured to make its inaugural appearance at the European Society of Cataract & Refractive Surgeons (ESCRS) prestigious 41st Congress, taking place in
World Sjögren’s Day, celebrated annually on July 23rd, is a significant annual event dedicated to providing support to millions of individuals living with Sjögren’s syndrome,
Study demonstrates the benefit of OmniLenz applied Omnigen in the early management of acute chemical eye injuries (CEI) in the first prospective study of its
Last week, attendees at the 2023 European Society of Ophthalmology (SOE) 15-17 June, Prague (https://soe2023.soevision.org) had the opportunity to learn about the latest clinical studies
Two Studies Find NuVision’s Omnigen Amniotic Membrane Effective in Improving Dry Eye Disease Symptomology Management of DED symptomology is challenging. One in four of us
